{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:45:58Z","timestamp":1779893158429,"version":"3.53.1"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Regression (total or partial) is a common phenomenon in melanoma. From a pathogenic perspective, it is highly complex and only partially understood, involving aspects of both the tumor and the individual. One of the determining factors is the clonal selection of the tumor, wherein some clones within the tumor survive while others perish. This clonal selection can sometimes occur as a selective mechanism after the initiation of a therapeutic intervention. In many of these cases, the effect is detrimental, because the surviving clone is resistant to the applied therapy. However, occasionally, the therapy can successfully select the less harmful clone. We present an example of the latter, where therapy with interferon induced regression of the metastatic-capable melanocytic population, with only the primary tumor melanocytic population persisting. To confirm this, we demonstrated <jats:italic toggle=\"yes\">BRAF<\/jats:italic> mutational similarity between the 2 populations, and an additional <jats:italic toggle=\"yes\">NRAS<\/jats:italic> mutation in the metastatic population, which was absent in the primary tumor.<\/jats:p>","DOI":"10.1097\/dad.0000000000002873","type":"journal-article","created":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T20:01:00Z","timestamp":1730404860000},"page":"46-49","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Selective Clonal Regression After Interferon Therapy in Metastatic Melanoma"],"prefix":"10.1097","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6617-2364","authenticated-orcid":false,"given":"Angel","family":"Fernandez-Flores","sequence":"first","affiliation":[{"name":"Department of Histopathology, University Hospital El Bierzo, Ponferrada, Spain; and"},{"name":"Department of Cellular Pathology, Hospital de la Reina, Ponferrada, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,10,31]]},"reference":[{"key":"R1-20241211","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ejso.2013.09.026","article-title":"Spontaneous regression of metastatic melanoma - clinical evidence of the abscopal effect","volume":"40","author":"Bramhall","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"R2-20241211","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/labinvest.2017.8","article-title":"Regression in primary cutaneous melanoma: etiopathogenesis and clinical significance","volume":"97","author":"Aung","year":"2017","journal-title":"Lab Invest"},{"key":"R3-20241211","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1365-2559.1992.tb00988.x","article-title":"Histological regression in primary cutaneous melanoma: recognition, prevalence and significance","volume":"20","author":"Blessing","year":"1992","journal-title":"Histopathology"},{"key":"R4-20241211","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/ijc.26471","article-title":"Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes","volume":"131","author":"Carretero","year":"2012","journal-title":"Int J Cancer"},{"key":"R5-20241211","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/ijc.2910320603","article-title":"Metastatic malignant melanoma: regression induced by combined treatment with interferon [HuIFN-alpha(Le)] and cimetidine","volume":"32","author":"Flodgren","year":"1983","journal-title":"Int J Cancer"},{"key":"R6-20241211","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/CMR.0000000000000935","article-title":"Tumour regression predicts better response to interferon therapy in melanoma patients: a retrospective single centre study","volume":"34","author":"Mez\u0151laki","year":"2024","journal-title":"Melanoma Res"},{"key":"R7-20241211","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1002\/1097-0142(196511)18:11<1399::AID-CNCR2820181104>3.0.CO;2-R","article-title":"Spontaneous regression of primary malignant melanomas with regional metastases","volume":"18","author":"Smith","year":"1965","journal-title":"Cancer"},{"key":"R8-20241211","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/CMR.0b013e328307ee4c","article-title":"Spontaneous regression of metastases from malignant melanoma: a case report","volume":"18","author":"Kalialis","year":"2008","journal-title":"Melanoma Res"},{"key":"R9-20241211","first-page":"4853","article-title":"Local cytokine availability elicits tumor rejection and systemic immunity through granulocyte-T-lymphocyte cross-talk","volume":"52","author":"Colombo","year":"1992","journal-title":"Cancer Res"},{"key":"R10-20241211","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pathol.2022.11.005","article-title":"Regression in cutaneous melanoma: histological assessment, immune mechanisms and clinical implications","volume":"55","author":"Aivazian","year":"2023","journal-title":"Pathology"},{"key":"R11-20241211","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1097\/00006534-199203000-00028","article-title":"Complete spontaneous regression of cutaneous primary malignant melanoma","volume":"89","author":"Bottger","year":"1992","journal-title":"Plast Reconstr Surg"},{"key":"R12-20241211","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/DAD.0b013e318165641a","article-title":"Complete regression of primary malignant melanoma","volume":"30","author":"Emanuel","year":"2008","journal-title":"Am J Dermatopathol"},{"key":"R13-20241211","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaad.2005.03.006","article-title":"Completely regressed primary cutaneous malignant melanoma with nodal and\/or visceral metastases: a report of 5 cases and assessment of the literature and diagnostic criteria","volume":"53","author":"High","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"R14-20241211","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1524-4725.1994.tb01635.x","article-title":"Metastatic malignant melanoma with spontaneous and complete regression of the primary lesion. Case report and review of the literature","volume":"20","author":"Shai","year":"1994","journal-title":"J Dermatol Surg Oncol"},{"key":"R15-20241211","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/jamadermatol.2015.2235","article-title":"Association of histologic regression in primary melanoma with sentinel lymph node status: a systematic review and meta-analysis","volume":"151","author":"Ribero","year":"2015","journal-title":"JAMA Dermatol"},{"key":"R16-20241211","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1080\/15384047.2017.1323596","article-title":"Immune surveillance in melanoma: from immune attack to melanoma escape and even counterattack","volume":"18","author":"Mahmoud","year":"2017","journal-title":"Cancer Biol Ther"},{"key":"R17-20241211","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1600-0625.2008.00779.x","article-title":"Immune modulation by melanoma-derived factors","volume":"17","author":"Ilkovitch","year":"2008","journal-title":"Exp Dermatol"},{"key":"R18-20241211","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/pcmr.12513","article-title":"Bidirectional cross talk between patient-derived melanoma and cancer-associated fibroblasts promotes invasion and proliferation","volume":"29","author":"Izar","year":"2016","journal-title":"Pigment Cell Melanoma Res"},{"key":"R19-20241211","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.ccell.2017.02.008","article-title":"Obstacles posed by the tumor microenvironment to T cell activity: a case for synergistic therapies","volume":"31","author":"Anderson","year":"2017","journal-title":"Cancer Cell"},{"key":"R20-20241211","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat Med"},{"key":"R21-20241211","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tig.2023.01.007","article-title":"Clonal selection parallels between normal and cancer tissues","volume":"39","author":"Salavaty","year":"2023","journal-title":"Trends Genet"},{"key":"R22-20241211","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1038\/s41467-020-18730-z","article-title":"Adaptation and selection shape clonal evolution of tumors during residual disease and recurrence","volume":"11","author":"Walens","year":"2020","journal-title":"Nat Commun"},{"key":"R23-20241211","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1158\/2159-8290.CD-20-1092","article-title":"Selection of oncogenic mutant clones in normal human skin varies with body site","volume":"11","author":"Fowler","year":"2021","journal-title":"Cancer Discov"},{"key":"R24-20241211","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/sj.bjc.6606030","article-title":"Targeting BRAF for patients with melanoma","volume":"104","author":"Arkenau","year":"2011","journal-title":"Br J Cancer"},{"key":"R25-20241211","first-page":"401","article-title":"Cascading adoptive cell therapy for metastatic melanoma","volume":"26","author":"Su","year":"2011","journal-title":"Cancer Biother Radiopharm"},{"key":"R26-20241211","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1158\/2326-6066.CIR-23-0757","article-title":"Melanoma clonal heterogeneity leads to secondary resistance after adoptive cell therapy with tumor-infiltrating lymphocytes","volume":"12","author":"K\u00f6nig","year":"2024","journal-title":"Cancer Immunol Res"},{"key":"R27-20241211","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1477-3163-3-6","article-title":"Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis","volume":"3","author":"Houben","year":"2004","journal-title":"J Carcinog"},{"key":"R28-20241211","first-page":"3468","article-title":"Screening of N-ras codon 61 mutations in paired primary and metastatic cutaneous melanomas: mutations occur early and persist throughout tumor progression","volume":"8","author":"Omholt","year":"2002","journal-title":"Clin Cancer Res"},{"key":"R29-20241211","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/cam4.50","article-title":"Targeting hyperactivation of the AKT survival pathway to overcome therapy resistance of melanoma brain metastases","volume":"2","author":"Niessner","year":"2013","journal-title":"Cancer Med"},{"key":"R30-20241211","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/1535-7163.MCT-08-0145","article-title":"BRAF and NRAS mutations in melanoma: potential relationships to clinical response to HSP90 inhibitors","volume":"7","author":"Banerji","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"R31-20241211","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0378-4274(93)90056-4","article-title":"Oncogene activation: c-raf-1 gene mutations in experimental and naturally occurring tumors","volume":"67","author":"Storm","year":"1993","journal-title":"Toxicol Lett"},{"key":"R32-20241211","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0065-2571(03)00002-5","article-title":"Raf kinases in lung tumor development","volume":"43","author":"Rapp","year":"2003","journal-title":"Adv Enzyme Regul"}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002873","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T23:00:43Z","timestamp":1733958043000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/DAD.0000000000002873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,31]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000002873","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,31]]}}}